Life Science Day

Focus on the new, Danish life science strategy and the importance of collaboration in the fight against COVID-19

  • TBD

1 day event

Danish

0,- DKK ex VAT
(app. 0,- EUR ex VAT)
50% DISCOUNT FOR PUBLIC INSTITUTIONS

At the moment there are no available dates for this course.

The day focuses on the new, Danish life science strategy, which will be launched shortly. A strategy that, after the COVID-19 crisis, aims to set an ambitious direction for one of Denmark's absolute positions of strength. Currently, the COVID-19 crisis has also emphasised the importance of collaboration between public and private actors. A topic the days’ presentations and debate will also put into perspective. 

Sign up here


Key words

  • Life science strategy
  • Collaboration

programme

11.00 - 11.10 Welcome

- Peter Drøidal, Chairman of Lif and Ida Sofie Jensen, CEO of Lif

11.10 - 11.25 Ambitions for life science in Denmark

- Simon Kollerup, Minister for Industry, Business and Financial Affairs

11.25 - 12.00 Key priorities for realising the life science potential

- Lars Fruergaard Jørgensen, President and CEO, Novo Nordisk
- Deborah Dunsire, President and CEO, H. Lundbeck A / S
- Catherine Mazzacco, President and CEO, LEO Pharma A / S
- Dorthe Mikkelsen, President Asia Pacific, MSD

12.00 - 12.25 The significance of collaboration for the fight against COVID-19

- Henrik Ullum, director of Statens Serum Institut

12.25 - 12.30 Thank you and goodbye


speakers

- Lars Fruergaard Jørgensen, President and CEO, Novo Nordisk

- Deborah Dunsire, President and CEO, H. Lundbeck A / S

- Catherine Mazzacco, President and CEO, LEO Pharma A / S

- Dorthe Mikkelsen, President Asia Pacific, MSD

- Simon Kollerup, Minister for Industry, Business and Financial Affairs

- Henrik Ullum, director of Statens Serum Institut

Want to know more about this event?

Contact Solveig Ristinge at +45 39 15 09 83 or sri@lif.dk

Send me a message